Rebecca Bagley

Executive Director, Clinical Sciences, Revumenib Lead @Syndax Pharmaceuticals

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Executive Director, Clinical Sciences, Revumenib Lead @Syndax Pharmaceuticals

View department →

SKILLS

BiotechnologyDrug DiscoveryOncologyClinical DevelopmentClinical StrategyBiomarkersClinical OperationsOrganizational SkillsClinical TrialsRegulatory AffairsLife SciencesPharmaceutical IndustryImmunologyCROPharmacologyAssay DevelopmentTranslational MedicinePublicationsDrug DevelopmentClinical Research

ABOUT REBECCA BAGLEY

Experienced clinical scientist in oncology from IND submission to post-approval of…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Rebecca Bagley — Executive Director, Clinical Sciences, Revumenib Lead at Syndax Pharmaceuticals in Boston, MA, US | Unifers